Atopic dermatitis, and the role for a ceramide-dominant, physiologic lipid-based barrier repair emulsion

Journal of Drugs in Dermatology

Volumn 12, Issue 9, 2013, Pages 1024-1027

  Kircik, Leon ^a,b   Hougeir, Firas ^c   Bikowski, Joseph ^d  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Physicians Skin Care PLLC   (United States)

^c Skin Care Center ^*

^d Skin Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CHOLESTEROL; CORTICOSTEROID; DERMATOLOGICAL AGENT; EPICERAM; FATTY ACID; FILAGGRIN; FLUTICASONE PROPIONATE; HUMECTANT; IMMUNOMODULATING AGENT; LINOLEIC ACID; LIPID; LIPID EMULSION; PSEUDOCERAMIDE 104; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; BIOTECHNOLOGY; CELL GROWTH; CONTROLLED DRUG RELEASE; CORTICOSTEROID THERAPY; CREAM; DERMATITIS; DISEASE SEVERITY; DRUG CONJUGATION; DRUG EFFICACY; DRUG FORMULATION; EPIDERMIS; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; KERATINOCYTE; LIPID MEMBRANE; MICROENCAPSULATION; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PRURITUS; REMISSION; RISK FACTOR; RISK REDUCTION; SKIN; SKIN FUNCTION; SKIN PERMEABILITY; STRATUM CORNEUM;

CERAMIDES; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; EMULSIONS; EPIDERMIS; EXCIPIENTS; HUMANS; LIPIDS; SKIN; SKIN PHYSIOLOGICAL PHENOMENA;

EID: 84883371130     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Proksch E, Fölster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci. 2006 Sep;43(3):159-69.
2. Proksch E, Fölster-Holst R, Bräutigam M, Sepehrmanesh M, Pfeiffer S, Jensen JM. Role of the epidermal barrier in atopic dermatitis. J Dtsch Dermatol Ges. 2009 Oct;7(10):899-910.
3. Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther. 2004;17:6-15.
4. Elias PM. Physiologic lipids for barrier repair in dermatology. In: Draelos ZD, ed. Cosmeceuticals, 1st ed. Philadelphia. Elsevier-Saunders; 2005:63-70.
5. Elias PM. The epidermal permeability barrier: from Saran Wrap to biosensor. In: Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor & Francis; 2006:25-32.
6. Proksch E, Elias PM. Epidermal barrier in atopic dermatitis. In: Bieber T, Leung DYM, eds. Atopic Dermatitis. New York: Marcel Dekker; 2002:123-143.
7. Del Rosso JQ, Levin J. The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol. 2011 Sep;4(9):22-42.
8. Koch PJ, Roop DR, Zhou Z. Cornified envelope and corneocyte-lipid envelope. In: Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor & Francis; 2006:97-110.
9. Tetsuji H. Cornified envelope. In: Rawlings AV, Leyden JJ, eds. Skin Moisturization, 2nd ed. New York: Informa Healthcare; 2009:83-97.
10. Haftek M, Simon M, Serre G. Corneodesmosomes: pivotal actors in stratum corneum adhesion and desquamation. In: Elias PM, Feingold KR. Skin Barrier. New York: Taylor & Francis; 2006:171-189.
11. DiNardo A, Wertz PW. Atopic dermatitis. In: Leyden JJ, Rawlings AV, eds. Skin Moisturization, 1st ed. New York: Marcel Dekker; 2002:165-178.
12. Rawlings AV, Scott IR, Harding CR, Bowser PA. Stratum corneum moisturization at the molecular level. J Invest Dermatol. 1994;103(5):731-740.
13. Menon GK, Norlen L. Stratum corneum ceramides and their role in skin barrier function. In: Leyden J, Rawlings A, eds. Skin Moisturization. New York, NY: Marcel Dekker, Inc.; 2002:31-60.
14. Imokawa G, Abe A, Higaki Y, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol. 1991;96:523-526.
15. Kligman AM. A brief history of how the dead stratum corneum became alive. In: Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor & Francis; 2006:15-24.
16. Del Rosso JQ. Understanding skin cleansers and moisturizers: the correlation of formulation science with the art of clinical use. Cosmet Dermatol. 2003;16:19-31.
17. Del Rosso JQ. The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the assessment of skin characteristics study. Cutis. 2009;84:72-76.
18. Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11):771-778.
19. Yamamoto A, Serizawa S, Ito M, et al. Stratum corneum abnormalities in atopic dermatitis. Arch Dermatol Res. 1991;283:219-223.
20. Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150:1136-1141.
21. Elias PM, Feingold KR. Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Semin Dermatol. 1992 Jun;11(2):176-82.
22. Elias PM, Feingold KM. Permeability barrier homeostasis. In: Elias PM, Feingold KR. Skin Barrier. New York: Taylor & Francis; 2006:337-361.
23. O'Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010:40:965-972.
24. Katagiri C, Sato J, Nomura J, et al. Changes in environmental humidity affect the water-holding property of the stratum corneum and its free amino acid content, and the expression of filaggrin in the epidermis of hairless mice. J Dermatol Sci. 2003;31:29-35.
25. McLean I. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol. 2008;128:2117-2119.
26. Johnson AW. Cosmeceuticals: function and the skin barrier. In: Draelos ZD. Cosmeceuticals. Philadelphia: Saunders-Elsevier; 2009:7-14.
27. Irvine AD, McClean WHI. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol. 2006;126:1200-1202.
28. Uitto J, McGrath JA. The role of fliaggrin in skin disease. In: Rawlings AV, Leyden JJ, eds. Skin Moisturization, 2nd ed. New York: Informa Health; 2009:57-67.
29. Del Rosso JQ. Moisturizers: function, formulation, and clinical applications. In: Draelos ZD. Cosmeceuticals.Philadelphia: Saunders Elsevier; 2009:97-102.
30. Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulationin moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol. 2009Dec;8(12):1106-11.
31. Kircik LH, Del Rosso JQ, Aversa D. Evaluating Clinical Use of a Ceramidedominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis. J Clin Aesthet Dermatol. 2011 Mar;4(3):34-40.
32. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, Williams ML, Elias PM. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002 Aug;47(2):198-208.
33. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus. Am J Clin Dermatol. 2004;5(4):217-23.